NO943070D0 - antitussives - Google Patents

antitussives

Info

Publication number
NO943070D0
NO943070D0 NO943070A NO943070A NO943070D0 NO 943070 D0 NO943070 D0 NO 943070D0 NO 943070 A NO943070 A NO 943070A NO 943070 A NO943070 A NO 943070A NO 943070 D0 NO943070 D0 NO 943070D0
Authority
NO
Norway
Prior art keywords
antitussives
delta
image
acceptable salt
active ingredient
Prior art date
Application number
NO943070A
Other languages
Norwegian (no)
Other versions
NO307496B1 (en
NO943070L (en
Inventor
Hiroshi Nagase
Junzo Kamei
Koji Kawai
Takashi Endo
Original Assignee
Toray Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries filed Critical Toray Industries
Publication of NO943070D0 publication Critical patent/NO943070D0/en
Publication of NO943070L publication Critical patent/NO943070L/en
Publication of NO307496B1 publication Critical patent/NO307496B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fats And Perfumes (AREA)
  • Saccharide Compounds (AREA)
  • Linear Motors (AREA)

Abstract

An antitussive containing a delta -opioid antagonist or a pharmacologically acceptable salt thereof as the active ingredient. It has a potent activity, does not give side effects such as impaired mentation, and can be administered perorally. <IMAGE>
NO943070A 1992-12-22 1994-08-19 Use of a <parta> opioid antagonist for the preparation of an antitussive agent NO307496B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP34194792 1992-12-22
PCT/JP1993/001855 WO1994014445A1 (en) 1992-12-22 1993-12-22 Antitussive

Publications (3)

Publication Number Publication Date
NO943070D0 true NO943070D0 (en) 1994-08-19
NO943070L NO943070L (en) 1994-10-21
NO307496B1 NO307496B1 (en) 2000-04-17

Family

ID=18349997

Family Applications (1)

Application Number Title Priority Date Filing Date
NO943070A NO307496B1 (en) 1992-12-22 1994-08-19 Use of a <parta> opioid antagonist for the preparation of an antitussive agent

Country Status (11)

Country Link
US (1) US5714483A (en)
EP (1) EP0636371B1 (en)
KR (1) KR950700065A (en)
CN (1) CN1071117C (en)
AT (1) ATE166229T1 (en)
AU (1) AU674379B2 (en)
CA (1) CA2130457A1 (en)
DE (1) DE69318710T2 (en)
NO (1) NO307496B1 (en)
TW (1) TW366284B (en)
WO (1) WO1994014445A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU712012B2 (en) * 1995-09-26 1999-10-28 Toray Industries, Inc. Indole derivatives and medical application thereof
US6156762A (en) * 1997-01-16 2000-12-05 Toray Industries, Inc. Indolomorphinan derivative and agent for curing and preventing cerebral disorder
CA2264928A1 (en) * 1997-07-09 1999-01-21 Koji Kawai Antitussives
WO2001005795A1 (en) * 1999-07-19 2001-01-25 Toray Industries, Inc. Remedies or preventives for frequent urination or urinary incontinence
US20030153590A1 (en) * 2001-08-14 2003-08-14 Oy Contral Pharma Ltd Method of treating alcoholism or alcohol abuse
US20060052409A1 (en) * 2002-07-11 2006-03-09 Koji Kawai Therapeutic or preventive agent for nausea/vomiting
WO2006064780A1 (en) * 2004-12-14 2006-06-22 Shionogi & Co., Ltd. Therapeutic agent for constipation
CA2625495A1 (en) * 2005-10-11 2007-04-19 Toray Industries, Inc. Therapeutic agent for nausea and/or vomiting
WO2008001859A1 (en) * 2006-06-30 2008-01-03 School Juridical Person Kitasato Gakuen OPIOID δ RECEPTOR AGONIST

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4613668A (en) * 1983-12-22 1986-09-23 The United States Of America As Represented By The Department Of Health And Human Services Short total synthesis or morphinan compounds which uses cyclization of a cycloalkylcarbonyl compound selected from cyclopropylcarbonyl and cyclobutylcarbonyl
US4816586A (en) * 1987-07-29 1989-03-28 Regents Of The University Of Minnesota Delta opioid receptor antagonists
PT95069B (en) * 1989-08-24 1997-10-31 Searle & Co PROCESS FOR THE PREPARATION OF (+) - ISOMERS OF DERIVATIVES OF ENDOETANO / ENDOETANOEPOXIMOFINANO, UTEIS AS ANTI-TUSTIC AGENTS
JP2906654B2 (en) * 1989-11-28 1999-06-21 東レ株式会社 Immunosuppressant and method for producing the same
AU654275B2 (en) * 1991-04-30 1994-11-03 Ur Labs, Inc. Method for reducing emesis and nausea induced by the administration of an emesis-causing agent
JPH04342529A (en) * 1991-05-21 1992-11-30 Toray Ind Inc Anti-allergic drug

Also Published As

Publication number Publication date
NO307496B1 (en) 2000-04-17
ATE166229T1 (en) 1998-06-15
DE69318710T2 (en) 1998-09-10
US5714483A (en) 1998-02-03
CA2130457A1 (en) 1994-07-07
NO943070L (en) 1994-10-21
AU5715694A (en) 1994-07-19
EP0636371B1 (en) 1998-05-20
EP0636371A4 (en) 1995-03-01
KR950700065A (en) 1995-01-16
AU674379B2 (en) 1996-12-19
TW366284B (en) 1999-08-11
EP0636371A1 (en) 1995-02-01
WO1994014445A1 (en) 1994-07-07
CN1099617A (en) 1995-03-08
DE69318710D1 (en) 1998-06-25
CN1071117C (en) 2001-09-19

Similar Documents

Publication Publication Date Title
MX9802383A (en) Pyrimidine derivatives as 5ht2c-receptor antagonists.
CA2259148A1 (en) Solid oral dosage forms of valsartan
EP0497258A3 (en) Use of adenosine antagonists in the prevention and treatment of pancreatitis and ulcer
RS50485B (en) Therapeutic combinations comprising amlodipin and atorvastatin
GB2365772A (en) Factor
CA2143864A1 (en) Morphinan derivatives and pharmaceutical use thereof
AU3354895A (en) Novel medicinal use of 5ht3 antagonist
DK0535034T3 (en) Pharmaceutically active benzoquinazoline compounds
NO943070L (en) antitussives
EP0522173A4 (en) 4-desoxy-4-epipodophyllotoxin derivative or pharmaceutically acceptable salt thereof
DE59001121D1 (en) Antacidatabletten.
IT8920405A0 (en) PHARMACOLOGICALLY ACTIVE AMINOIMIDAZOPYRIDINES.
HU912594D0 (en) Solid, orally usable forms containing iphosphamide as active agents
EA199800573A1 (en) TABLETS WITH HIGH CONTENT OF FAMCYCLOVIR
DE68908838D1 (en) Pharmaceutically active dithiokete derivatives.
MX9203221A (en) PHARMACOLOGICALLY ACTIVE COMPOUND, PREPARATION AND USE.
EP0509098A4 (en) Ataractic
FR2715849B1 (en) Solid administration form with rapid disintegration of an active ingredient.
AP9200405A0 (en) Pharmaceutical formulations comprised of micronised halofantrine.
RU96115480A (en) MEDICINAL PREPARED WITH CHOLOLYTOLITIC ACTION
IT1229230B (en) PHARMACOLOGICALLY ACTIVE PIPERIDYLIMIDAZOPYRIDINS.
ZA917367B (en) Pharmacologically active compounds and use.
ITMI910596A1 (en) PHARMACOLOGICALLY ACTIVE GLYCERODIVIVES
ITMI921865A1 (en) PHARMACOLOGICALLY ACTIVE GLYCEROPHOSPHODERIVATES
FI961410A0 (en) Pharmacologically active compounds acting on the central nervous system

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN JUNE 2003